Krajina: Malta
Jazyk: angličtina
Zdroj: Malta Medicines Authority
GADOXETIC ACID, DISODIUM
Bayer Public Limited Company 400 South Oak Way, Reading Berkshire RG2 6AD, United Kingdom
V08CA10
GADOXETIC ACID, DISODIUM
SOLUTION FOR INJECTION
GADOXETIC ACID, DISODIUM
POM
CONTRAST MEDIA
Withdrawn
2012-02-16
Page 1 of 7 PACKAGE LEAFLET: INFORMATION FOR THE USER PRIMOVIST 0.25 MMOL/ML, SOLUTION FOR INJECTION Gadoxetic acid, disodium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, please ask your doctor giving you Primovist (the radiologist) or the hospital/MRI-centre personnel. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or radiologist. IN THIS LEAFLET: 1. What PRIMOVIST is and what it is used for 2. Before you are given PRIMOVIST 3. How to use PRIMOVIST 4. Possible side effects 5. How to store PRIMOVIST 6. Further information 1. WHAT PRIMOVIST IS AND WHAT IT IS USED FOR Primovist is a contrast medium for magnetic resonance imaging (MRI) of the liver. It is used to help detect and diagnose changes that may be found in the liver. Abnormal signs within the liver can be better evaluated (as to number, size, and distribution). Primovist can also help the doctor determine the nature of any abnormalities, thereby increasing the confidence one can have in the diagnosis. It is provided as a solution for intravenous injection. This medicine is for diagnostic use only. MRI is a form of medical diagnostic imaging that forms pictures after water molecules have been detected in normal and abnormal tissues. This is done using a complex system of magnets and radiowaves. 2. BEFORE YOU ARE GIVEN PRIMOVIST DO NOT USE PRIMOVIST - if you are allergic (hypersensitive) to gadoxetic acid, disodium or any of the other ingredients of Primovist lis Prečítajte si celý dokument
Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ▼ Primovist 0.25 mmol/ml,_ _solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 0.25 mmol gadoxetate disodium (Gd-EOB-DTPA disodium),_ _equivalent to 181.43 mg gadoxetate disodium. 1 injection vial with 5.0 ml contains 907 mg gadoxetate disodium, 1 injection vial with 7.5 ml contains 1361 mg gadoxetate disodium, 1 injection vial with 10.0 ml contains 1814 mg gadoxetate disodium. Contains 11.7 mg sodium/ ml. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Clear, colourless to pale yellow liquid free from visible particles. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Primovist is indicated for the detection of focal liver lesions and provides information on the character of lesions in T1-weighted magnetic resonance imaging (MRI). This medicinal product is for diagnostic use by intravenous administration only_._ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION METHOD OF ADMINISTRATION Primovist is a ready-to-use aqueous solution to be administered undiluted as an intravenous bolus injection at a flow rate of about 2 ml/sec. After the injection of the contrast medium the intravenous cannula / line should be flushed using sterile 9 mg/ml (0.9 %) saline solution. For detailed imaging information refer to section 5.1. For additional instructions see section 6.6. POSOLOGY The recommended dose of Primovist is: ADULTS: 0.1 ml per kg body weight Primovist. REPEATED USE: No clinical information is available about repeated use of Primovist. Page 2 of 10 ADDITIONAL INFORMATION ON SPECIAL PO Prečítajte si celý dokument